GLYCOMIMETICS INC Business Finance Contracts & Agreements
16 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Release Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (4)
- Warrant Agreements (4)
- Form of Registration Rights Agreement (Filed With SEC on October 29, 2024)
- Form of GlycoMimetics Securities Purchase Agreement (Filed With SEC on October 29, 2024)
- Release Agreement, dated February 13, 2023, by and between the Company and Armand Girard (Filed With SEC on May 3, 2023)
- Form of Stock Option Grant Notice and Stock Option Agreement under the GlycoMimetics, Inc. Inducement Plan (Filed With SEC on February 28, 2020)
- Underwriting Agreement by and among GlycoMimetics, Inc., Jefferies LLC and Cowen and Company, LLC, dated March 20, 2018 (Filed With SEC on March 21, 2018)
- 7,000,000 Shares GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on May 25, 2017)
- 3,300,000 Shares GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 17, 2016)
- GLYCOMIMETICS, INC. common Stock (par value $0.001 per share) SALES AGREEMENT (Filed With SEC on March 1, 2016)
- GLYCOMIMETICS, INC. 2013EMPLOYEE STOCK PURCHASE PLAN ADOPTEDBY THE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS: OCTOBER 25, 2013 (Filed With SEC on October 28, 2013)
- [Number of Shares] GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. 2013EMPLOYEE STOCK PURCHASE PLAN ADOPTEDBY THE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS: [], 2013 (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 4, 2013)
- SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 4, 2013)
